223 related articles for article (PubMed ID: 12412858)
1. Carcinogenicity of saccharin in laboratory animals and humans: letter to Dr. Harry Conacher of Health Canada.
Bell W; Clapp R; Davis D; Epstein S; Farber E; Fox DA; Holub B; Jacobson MF; Lijinsky W; Millstone E; Reuber MD; Suzuki D; Temple NJ
Int J Occup Environ Health; 2002; 8(4):387-93. PubMed ID: 12412858
[TBL] [Abstract][Full Text] [Related]
2. Saccharin mechanistic data and risk assessment: urine composition, enhanced cell proliferation, and tumor promotion.
Whysner J; Williams GM
Pharmacol Ther; 1996; 71(1-2):225-52. PubMed ID: 8910956
[TBL] [Abstract][Full Text] [Related]
3. Saccharin: past, present, and future.
Cohen SM
J Am Diet Assoc; 1986 Jul; 86(7):929-31. PubMed ID: 3722660
[TBL] [Abstract][Full Text] [Related]
4. Saccharin and chemical carcinogenesis.
Med Lett Drugs Ther; 1977 Sep; 19(18):75-6. PubMed ID: 895675
[No Abstract] [Full Text] [Related]
5. Saccharin--bitter aftertaste?
Hoover R
N Engl J Med; 1980 Mar; 302(10):573-5. PubMed ID: 7351893
[No Abstract] [Full Text] [Related]
6. The male rat carcinogens limonene and sodium saccharin are not mutagenic to male Big Blue rats.
Turner SD; Tinwell H; Piegorsch W; Schmezer P; Ashby J
Mutagenesis; 2001 Jul; 16(4):329-32. PubMed ID: 11420401
[TBL] [Abstract][Full Text] [Related]
7. Saccharin and its salts.
IARC Monogr Eval Carcinog Risks Hum; 1999; 73():517-624. PubMed ID: 10804968
[No Abstract] [Full Text] [Related]
8. Artificial sweeteners as urinary bladder carcinogens.
Bryan GT; Yoshida O
Arch Environ Health; 1971 Jul; 23(1):6-12. PubMed ID: 4996434
[No Abstract] [Full Text] [Related]
9. Comments on the potential carcinogenicity of saccharin.
Van Duuren BL
J Environ Pathol Toxicol; 1980 Mar; 3(4 Spec No):373-6. PubMed ID: 6771358
[No Abstract] [Full Text] [Related]
10. The saccharin question re-examined: an A.D.A. Statement.
J Am Diet Assoc; 1979 May; 74(5):574-81. PubMed ID: 438456
[No Abstract] [Full Text] [Related]
11. Some non-nutritive sweetening agents.
IARC Monogr Eval Carcinog Risk Chem Hum; 1980 Mar; 22():1-185. PubMed ID: 6930363
[No Abstract] [Full Text] [Related]
12. Effect of regenerative hyperplasia on the urinary bladder: carcinogenicity of sodium saccharin and N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
Cohen SM; Murasaki G; Fukushima S; Greenfield RE
Cancer Res; 1982 Jan; 42(1):65-71. PubMed ID: 7053869
[No Abstract] [Full Text] [Related]
13. [Toxicology of chemical sweetening agents].
Göttinger E
Wien Med Wochenschr; 1971 Jun; 121(25):515-6. PubMed ID: 5129945
[No Abstract] [Full Text] [Related]
14. Saccharin: a toxicological and historical perspective.
Arnold DL; Krewski D; Munro IC
Toxicology; 1983; 27(3-4):179-256. PubMed ID: 6353664
[TBL] [Abstract][Full Text] [Related]
15. Study of sodium saccharin co-carcinogenicity in the rat.
West RW; Sheldon WG; Gaylor DW; Allen RR; Kadlubar FF
Food Chem Toxicol; 1994 Mar; 32(3):207-13. PubMed ID: 8157214
[TBL] [Abstract][Full Text] [Related]
16. Saccharin. Review of safety issues. Council on Scientific Affairs.
JAMA; 1985 Nov; 254(18):2622-4. PubMed ID: 3932690
[TBL] [Abstract][Full Text] [Related]
17. Saccharin: the problem with sucrose substitutes.
Felice PR; Thomas JA
J Sch Health; 1979 May; 49(5):284-5. PubMed ID: 110983
[No Abstract] [Full Text] [Related]
18. Effects of three sweeteners on rat urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)-nitrosamine.
Hagiwara A; Fukushima S; Kitaori M; Shibata M; Ito N
Gan; 1984 Sep; 75(9):763-8. PubMed ID: 6500232
[TBL] [Abstract][Full Text] [Related]
19. Inhibition by aspirin of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide initiation and sodium saccharin promotion of urinary bladder carcinogenesis in male F344 rats.
Sakata T; Hasegawa R; Johansson SL; Zenser TV; Cohen SM
Cancer Res; 1986 Aug; 46(8):3903-6. PubMed ID: 3731063
[TBL] [Abstract][Full Text] [Related]
20. Some sweetness left.
Nature; 1970 Aug; 227(5257):436. PubMed ID: 5428456
[No Abstract] [Full Text] [Related]
[Next] [New Search]
